Bowenpharm

Worcester, United States Founded: 2021 • Age: 5 yrs Acquired By Utime
Pharmaceutical research and clinical solutions are developed by Bowenpharm.

About Bowenpharm

Bowenpharm is a company based in Worcester (United States) founded in 2021 was acquired by Utime in August 2024. Bowenpharm operates in a competitive market with competitors including PPD, Cambrian BioPharma, Medicus Pharma, H.U. Group Holdings and DM Clinical, among others.

  • Headquarter Worcester, United States
  • Sectors
    Healthcare
  • Website bowenpharm.com
  • Acquired by Utime (Aug 2024)
Key Metrics

Investors in Bowenpharm

Bowenpharm has secured backing from 1 investor. Prominent investors backing the company include Utime.

All
InvestorDescriptionFounded YearDomainLocation
Operates a direct-to-consumer brand for multi-category mobile accessories.
2019utimeworld.comShenzhen, China
Premium access

Investor details for Bowenpharm

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Bowenpharm

2 dated milestones of Bowenpharm across 3 years, from founding to its latest funding, stage changes and deals.

  1. Founded Bowenpharm is founded.
  2. Exit Acquired by Utime.

Competitors of Bowenpharm

Bowenpharm operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PPD, Cambrian BioPharma, Medicus Pharma, H.U. Group Holdings and DM Clinical, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
ppd.com1985Wilmington, United States––
CRO providing diversified clinical development services
cambrianbio.com2019Brooklyn, United States$211.46M–
Medicines and therapies are developed for healthcare applications.
medicuspharma.com2008Toronto, Canada––
Clinical stage, multi-strategy holding company focused on investing in and accelerating novel therapies in the biotechnology and life sciences industry
hugp.com1950Shinjuku, Japan––
Provider of clinical testing, diagnostics, and healthcare services. This entity offers a range of services encompassing laboratory testing and related services, in-vitro diagnostics, healthcare-related services, and research and development. Their activities include supporting research in clinical laboratory medicine, fostering technological advancements, and contributing to the overall progress of medical science and healthcare technology. They also engage in intellectual property activities and have initiatives addressing public health concerns.
dmclinicalresearch.com2006Houston, United States––
Conducts Phase I-IV clinical trials connecting patients with physicians for medical research.
ipharma.ru2012Moscow, Russia––
Serves as a contract research organization focused on drug clinical trials.
crh-hamburg.de2004Hamburg, Germany––
Provider of clinical research of phases II, III and IV from different indications spheres of human medicine
excelsus-stat.com2014Montreal, Canada––
CRO focused on clinical development for dermatology drugs, site management, and patient recrutiment services
rayatherapeutic.com2019Montreal, Canada––
Provides comprehensive clinical trial design services for various diseases.
Premium access

Detailed competitors of Bowenpharm

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Similar companies to Bowenpharm

10 companies that operate in the same segment as Bowenpharm (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M1,820
Drug discovery and development services are provided to biopharma sector.
1993Hamburg, Hamburg, GermanyUSD 25 MUSD 926.33 M4,830
Drug discovery and development services for small molecules are provided.
2003Beijing, ChinaUSD 320 M–476
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 255.15 MUSD 374.1 M4,490
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M12,470
Pharmaceutical products for treating multiple diseases are provided.
1849New York, New York, United StatesUSD 8 MUSD 266.99 M1,770
Provider of laboratory tests for physicians
1969Burlington, Vermont, United States–USD 13.95 B70,000
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M4,260
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Bowenpharm

Bowenpharm was founded in 2021.

Bowenpharm is headquartered in Worcester, United States. It is registered at Worcester, Massachusetts, United States.

Bowenpharm was founded in 2021 and is based in Worcester, United States. Operations center on clinical research within the pharmaceutical sector, where services and products are provided to support drug development. Research activities encompass pharmaceutical sciences and clinical pharmacy practices. Affiliations with academic pharmacists and researchers are maintained. Efforts are directed toward expanding pharmaceutical knowledge and enhancing patient outcomes via structured research and educational initiatives.

Bowenpharm's top competitors include PPD, Cambrian BioPharma and Medicus Pharma.

Bowenpharm has 1 investor. Key investors include Utime.

Yes. Bowenpharm was acquired by Utime in August 2024.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available